Acute Urinary Retention News and Research

RSS
Urinary retention is the inability to empty the bladder. With chronic urinary retention, you may be able to urinate, but you have trouble starting a stream or emptying your bladder completely. You may urinate frequently; you may feel an urgent need to urinate but have little success when you get to the toilet; or you may feel you still have to go after you’ve finished urinating. With acute urinary retention, you can’t urinate at all, even though you have a full bladder. Acute urinary retention is a medical emergency requiring prompt action. Chronic urinary retention may not seem life threatening, but it can lead to serious problems and should also receive attention from a health professional.
Researchers report first case of acute myelitis due to Zika virus infection

Researchers report first case of acute myelitis due to Zika virus infection

Botulinum toxin A effective for treating bladder disorders

Botulinum toxin A effective for treating bladder disorders

Antimuscarinics plus α-blockers ‘recommended for male LUTS’

Antimuscarinics plus α-blockers ‘recommended for male LUTS’

Mirabegron reduces frequency of incontinence episodes in phase III trial

Mirabegron reduces frequency of incontinence episodes in phase III trial

Thulium vapoenucleation well-tolerated for treating benign prostate obstruction

Thulium vapoenucleation well-tolerated for treating benign prostate obstruction

New embolization procedure may bring hope to men with enlarged prostate

New embolization procedure may bring hope to men with enlarged prostate

Treatment for acute urinary retention due to BPH varies among countries

Treatment for acute urinary retention due to BPH varies among countries

FDA approves Valeant's Potiga Tablets for treatment of partial-onset seizures

FDA approves Valeant's Potiga Tablets for treatment of partial-onset seizures

FDA issues Complete Response letter for Avodart sNDA for reduction of prostate cancer risk

FDA issues Complete Response letter for Avodart sNDA for reduction of prostate cancer risk

Recordati, Nymox sign European licensing agreement for BPH investigational drug, NX-1207

Recordati, Nymox sign European licensing agreement for BPH investigational drug, NX-1207

Nymox awarded federal grant for NX-1207 Phase III BPH clinical trial program

Nymox awarded federal grant for NX-1207 Phase III BPH clinical trial program

Nymox updates NX-1207 Phase 3 pivotal trials for benign prostatic hyperplasia

Nymox updates NX-1207 Phase 3 pivotal trials for benign prostatic hyperplasia

Nymox provides update on NX-1207 Phase 3 program for benign prostatic hyperplasia

Nymox provides update on NX-1207 Phase 3 program for benign prostatic hyperplasia

Update on Nymox Pharmaceutical's Phase 3 program for NX-1207

Update on Nymox Pharmaceutical's Phase 3 program for NX-1207

Enlarged prostate: Dutasteride-tamsulosin combination therapy more effective

Enlarged prostate: Dutasteride-tamsulosin combination therapy more effective

Tru-flo urinary catheter valve from ProtekMed

Tru-flo urinary catheter valve from ProtekMed

AbbeyMoor Medical's The Spanner temporary prostatic stent insertion procedure receives Category I CPT code

AbbeyMoor Medical's The Spanner temporary prostatic stent insertion procedure receives Category I CPT code

Long-term complications for children fed with melamine contaminated products

Long-term complications for children fed with melamine contaminated products

Nymox nears completion of benign prostatic hyperplasia drug trial

Nymox nears completion of benign prostatic hyperplasia drug trial

Urinary complications in men over 45

Urinary complications in men over 45